DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,372 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,199,280 | +300.2% | 4,800 | +300.0% | 0.34% | +340.8% |
| Q1 2024 | $299,664 | -19.0% | 1,200 | -25.0% | 0.08% | -22.4% |
| Q4 2023 | $370,144 | -6.8% | 1,600 | 0.0% | 0.10% | -12.5% |
| Q3 2023 | $396,960 | +3.4% | 1,600 | 0.0% | 0.11% | +8.7% |
| Q2 2023 | $384,000 | -100.0% | 1,600 | -59.0% | 0.10% | -69.3% |
| Q3 2022 | $1,007,331,000 | -5.4% | 3,900 | -7.1% | 0.34% | +3.1% |
| Q2 2022 | $1,064,784,000 | +57.8% | 4,200 | +82.6% | 0.33% | +84.2% |
| Q1 2022 | $674,659,000 | -10.8% | 2,300 | 0.0% | 0.18% | -6.3% |
| Q4 2021 | $756,723,000 | +8.1% | 2,300 | 0.0% | 0.19% | -1.6% |
| Q3 2021 | $700,212,000 | +8.7% | 2,300 | -4.2% | 0.19% | +17.1% |
| Q2 2021 | $644,064,000 | +19.2% | 2,400 | 0.0% | 0.16% | +13.1% |
| Q1 2021 | $540,192,000 | -2.7% | 2,400 | -4.0% | 0.14% | -6.5% |
| Q4 2020 | $555,350,000 | -79.2% | 2,500 | -79.8% | 0.16% | -81.3% |
| Q3 2020 | $2,670,092,000 | +11.9% | 12,400 | -8.1% | 0.83% | +12.5% |
| Q2 2020 | $2,387,205,000 | +88.5% | 13,500 | +47.5% | 0.74% | +50.4% |
| Q1 2020 | $1,266,452,000 | -9.8% | 9,150 | 0.0% | 0.49% | +17.2% |
| Q4 2019 | $1,404,342,000 | +5.1% | 9,150 | -1.1% | 0.42% | -4.8% |
| Q3 2019 | $1,335,978,000 | -15.4% | 9,250 | -16.3% | 0.44% | -3.5% |
| Q2 2019 | $1,579,266,000 | +625.0% | 11,050 | +569.7% | 0.46% | +610.9% |
| Q1 2019 | $217,833,000 | +14.2% | 1,650 | -10.8% | 0.06% | +3.2% |
| Q4 2018 | $190,772,000 | -10.0% | 1,850 | -5.1% | 0.06% | +5.1% |
| Q3 2018 | $211,887,000 | +13.0% | 1,950 | +2.6% | 0.06% | +9.3% |
| Q2 2018 | $187,492,000 | +0.8% | 1,900 | 0.0% | 0.05% | 0.0% |
| Q1 2018 | $186,029,000 | +5.5% | 1,900 | 0.0% | 0.05% | +12.5% |
| Q4 2017 | $176,358,000 | -70.8% | 1,900 | -76.4% | 0.05% | -41.5% |
| Q1 2014 | $603,750,000 | -2.8% | 8,050 | 0.0% | 0.08% | -13.7% |
| Q4 2013 | $621,460,000 | – | 8,050 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |